These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32522898)

  • 1. Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis.
    Mori H; Ishibashi T; Inagaki T; Okazawa M; Masaki T; Asano R; Manabe Y; Ohta-Ogo K; Narazaki M; Ishibashi-Ueda H; Kumanogoh A; Nakaoka Y
    Circ J; 2020 Jun; 84(7):1163-1172. PubMed ID: 32522898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.
    Hashimoto-Kataoka T; Hosen N; Sonobe T; Arita Y; Yasui T; Masaki T; Minami M; Inagaki T; Miyagawa S; Sawa Y; Murakami M; Kumanogoh A; Yamauchi-Takihara K; Okumura M; Kishimoto T; Komuro I; Shirai M; Sakata Y; Nakaoka Y
    Proc Natl Acad Sci U S A; 2015 May; 112(20):E2677-86. PubMed ID: 25941359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice.
    Chen Y; Li C; Weng D; Song L; Tang W; Dai W; Yu Y; Liu F; Zhao M; Lu C; Chen J
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):62-72. PubMed ID: 24291675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
    Zawia A; Arnold ND; West L; Pickworth JA; Turton H; Iremonger J; Braithwaite AT; Cañedo J; Johnston SA; Thompson AAR; Miller G; Lawrie A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):430-445. PubMed ID: 33147993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.
    Maston LD; Jones DT; Giermakowska W; Howard TA; Cannon JL; Wang W; Wei Y; Xuan W; Resta TC; Gonzalez Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L609-L624. PubMed ID: 28213473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension.
    Masaki T; Okazawa M; Asano R; Inagaki T; Ishibashi T; Yamagishi A; Umeki-Mizushima S; Nishimura M; Manabe Y; Ishibashi-Ueda H; Shirai M; Tsuchimochi H; Pearson JT; Kumanogoh A; Sakata Y; Ogo T; Kishimoto T; Nakaoka Y
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PM2.5 exposure aggravates left heart failure induced pulmonary hypertension.
    Chen JJ; Ma WM; Yuan JL; Cui LQ
    Acta Cardiol; 2019 Jun; 74(3):238-244. PubMed ID: 30348056
    [No Abstract]   [Full Text] [Related]  

  • 10. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LPS induced pyroptosis exacerbates BMPR2 signaling deficiency to potentiate SLE-PAH.
    Xing Y; Zhao J; Zhou M; Jing S; Zhao X; Mao P; Qian J; Huang C; Tian Z; Wang Q; Zeng X; Li M; Yang J
    FASEB J; 2021 Dec; 35(12):e22044. PubMed ID: 34818449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
    Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
    PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
    Chen M; Shen H; Zhu L; Yang H; Ye P; Liu P; Gu Y; Chen S
    J Cell Physiol; 2019 Aug; 234(10):17482-17493. PubMed ID: 30786011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency.
    Shi Y; Tsuboi N; Furuhashi K; Du Q; Horinouchi A; Maeda K; Kosugi T; Matsuo S; Maruyama S
    J Immunol; 2014 Nov; 193(10):5129-39. PubMed ID: 25281714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
    Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
    Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.
    Chowdhary VR; Grande JP; Luthra HS; David CS
    Rheumatology (Oxford); 2007 Sep; 46(9):1405-10. PubMed ID: 17576695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
    Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
    Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.
    Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B
    J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.